Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic personnel shuffle

This article was originally published in The Gray Sheet

Executive Summary

Charles Swanson is heading up Medtronic's corporate regulatory affairs office following the Aug. 31 retirement of Peter Chevalier, former VP and chief quality and regulatory officer at the company. Swanson, who assumes the title VP-corporate regulatory affairs effective Sept. 1, had led the regulatory affairs department at Medtronic's pacing division. Senior Legal Counsel Robert Klepinski also joins the corporate regulatory affairs office, as does Kenneth Kopesky, director, pacing regulatory compliance. Former VP Corporate Regulatory Affairs Fred Halverson is named VP-international regulatory strategy and reimbursement policy
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel